Science In Sport ( (GB:SIS) ) has provided an announcement.
Science in Sport plc reported its audited final results for the year ending December 31, 2024, showcasing a significant turnaround in its operating model despite a 17.2% drop in revenue to £51.9 million. The company achieved a notable 112.7% increase in underlying EBITDA to £4.2 million, reflecting improved profitability due to operational efficiencies and cost savings, including exiting uncommercial marketing contracts and restructuring its leadership team. The company completed an £8.5 million equity fundraising and amended banking facilities to support growth and profitability. Looking ahead, Science in Sport aims to continue its strategic focus on profitable revenue growth, margin improvements, and cash generation, with a recent agreement for an all-cash acquisition by bd Capital.
More about Science In Sport
Science in Sport plc is a leading sports nutrition business headquartered in London, specializing in innovative nutrition products for professional athletes, sports enthusiasts, and the active lifestyle community. The company operates two prominent brands: PhD Nutrition, targeting the active lifestyle community with high-quality, innovative products, and SiS, focusing on endurance nutrition for elite athletes and professional sports teams. These brands are distributed through digital platforms, third-party online sites, and extensive retail channels both in the UK and internationally.
YTD Price Performance: 26.92%
Average Trading Volume: 308,842
Technical Sentiment Signal: Hold
Current Market Cap: £75.98M
See more data about SIS stock on TipRanks’ Stock Analysis page.